Home 2023

Laws

Icahn Sues Illumina’s Ex-CEO, Board, Alleging Breach of Duty
GEN Edge

Icahn Sues Illumina’s Ex-CEO, Board, Alleging Breach of Duty

Alex Philippidis -
0
Illumina Links Grail Divestiture to Losing European Or U.S. Appeals
Industry News

Illumina Links Grail Divestiture to Losing European Or U.S. Appeals

Alex Philippidis -
0
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Drug Discovery

Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb

Alex Philippidis -
0
After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?
Drug Discovery

After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?

Uduak Thomas -
0
Illumina Vows Appeal of $479M Fine for Acquiring Grail before EC Approval
News

Illumina Vows Appeal of $479M Fine for Acquiring Grail before EC Approval

Alex Philippidis -
0
Big Pharma Leadership Decries the Inflation Reduction Act
Artificial Intelligence

Big Pharma Leadership Decries the Inflation Reduction Act

Jonathan D Grinstein, PhD -
0
Locus Fermentation Solutions Announces $117 Million Financing
Bioprocessing

Locus Fermentation Solutions Announces $117 Million Financing

John Sterling -
0
Book Review: The Exceptions
Insights

Book Review: The Exceptions

Julianna LeMieux, PhD -
19
Elementary Claim: Sherlock Gains Patent Rights for Cas12 in Diagnostics
Drug Discovery

Elementary Claim: Sherlock Gains Patent Rights for Cas12 in Diagnostics

Alex Philippidis -
0
U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care
Bioprocessing

U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

John Sterling -
0
123...61Page 1 of 61
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.